No Significant Differences In BioGaia’s Diabetes Study

In 2012 BioGaia initiated a double-blind, placebo-controlled study to
investigate the effects of Lactobacillus reuteri Protectis on blood glucose in
type 2 diabetics. Despite positive results from an earlier pilot study no
significant differences between the groups were seen in this study.
Forty-five patients with type 2 diabetes were included in the 12-week long
study. The analysis of the results will continue to capitalise on as much
knowledge as possible.